Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Ipsen |
Recipient: You |
Company: Array BioPharma |
Recipient: You |
Company: AstraZeneca/MedImmune |
Recipient: You |
Company: Cancer Commons |
Recipient: You |
Company: Legend Biotech |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Celgene |
Recipient: Your Institution |
Company: Bristol-Myers Squibb |
Recipient: Your Institution |
Company: AstraZeneca/MedImmune |
Recipient: Your Institution |
Company: Merck Serono |
Recipient: Your Institution |
Company: Agios |
Recipient: Your Institution |
Company: Five Prime Therapeutics |
Recipient: Your Institution |
Company: MedImmune |
Recipient: Your Institution |
Company: ArQule |
Recipient: Your Institution |
Company: Genentech |
Recipient: Your Institution |
Company: Sillajen |
Recipient: Your Institution |
Company: CASI Pharmaceuticals |
Recipient: Your Institution |
Company: Immunesensor |
Recipient: Your Institution |
Company: Tolero Pharmaceuticals |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|